104 related articles for article (PubMed ID: 23509314)
41. Remission of invasive thymoma due to chemotherapy. Two patients treated with cyclophosphamide, doxorubicin, and vincristine.
Loehrer PJ; Bonomi P; Goldman S; Reddy S; Faber LP; Jensik R; Dainauskas JR
Chest; 1985 Mar; 87(3):377-80. PubMed ID: 3971764
[TBL] [Abstract][Full Text] [Related]
42. An extraordinary case of subcutaneous invasive thymoma.
Herde M; Gambichler T; Hoffmann K; Altmeyer P; Stücker M
J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):537-8. PubMed ID: 12428860
[No Abstract] [Full Text] [Related]
43. Undifferentiated epithelial-rich invasive malignant thymoma: complete response to cisplatin, vinblastine, and bleomycin therapy.
Dy C; Calvo FA; Mindán JP; Aparicio LA; Algarra SM; Gil A; González F; Harguindey S
J Clin Oncol; 1988 Mar; 6(3):536-42. PubMed ID: 2450971
[TBL] [Abstract][Full Text] [Related]
44. [A case of non-resectable thymoma which responded to the administration of adriamycin, vindesine and 5-FU].
Sagara N; Kurooka K; Mori K; Kayama H; Haeno Y; Hara S; Yasutomi M
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3532-4. PubMed ID: 3789761
[TBL] [Abstract][Full Text] [Related]
45. Total remission of thymus carcinoma after treatment with intravenous immunoglobulin.
Murie-Fernández M; Gurpide A; de la Cruz S; de Castro P
Clin Transl Oncol; 2006 Sep; 8(9):697-9. PubMed ID: 17005475
[TBL] [Abstract][Full Text] [Related]
46. Advanced-Stage Thymoma Associating Multiple Paraneoplastic Syndromes with Good Response to Oral Corticosteroids and Topical Tacrolimus.
Sánchez-Pérez S; Monteagudo-Castro C; Martín-Hernández JM; Ramón-Quiles MD
Actas Dermosifiliogr (Engl Ed); 2019; 110(1):60-62. PubMed ID: 29887166
[No Abstract] [Full Text] [Related]
47. Advanced inoperable type B3 thymoma: monitoring of a novel therapeutic approach with radio-chemotherapy and sorafenib by FDG-PET and CT.
Winder T; Schuster A; Becherer A; Gasser K; De Vries A; Gruber-Moesenbacher U; Muendlein A; Drexel H; Lang A
Nuklearmedizin; 2010; 49(5):N41-3. PubMed ID: 20931150
[No Abstract] [Full Text] [Related]
48. Best cases from the AFIP: urachal carcinoma.
Koster IM; Cleyndert P; Giard RW
Radiographics; 2009; 29(3):939-42. PubMed ID: 19448126
[No Abstract] [Full Text] [Related]
49. Dasatinib induces a response in malignant thymoma.
Chuah C; Lim TH; Lim AS; Tien SL; Lim CH; Soong R; Lee F; Linn YC; Goh YT; Cheah FK; Loh AH
J Clin Oncol; 2006 Dec; 24(34):e56-8. PubMed ID: 17135636
[No Abstract] [Full Text] [Related]
50. [Blindness and symmetrical neurological deficit in a patient with colon cancer receiving adjuvant chemotherapy: is it always cancer?].
Leshem Y; Fennig S; Talianski E; Greenberg G; Wolf I
Harefuah; 2014 Nov; 153(11):650-1, 687. PubMed ID: 25563024
[TBL] [Abstract][Full Text] [Related]
51. The role of chemotherapy in malignant thymoma.
Coperchini ML; Zalcberg JR
Aust N Z J Med; 1996 Jun; 26(3):423. PubMed ID: 8811223
[No Abstract] [Full Text] [Related]
52. Chemotherapy for malignant thymoma.
Chahinian AP; Holland JF; Bhardwaj S
Ann Intern Med; 1983 Nov; 99(5):736. PubMed ID: 6638737
[No Abstract] [Full Text] [Related]
53. Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil.
Truman N; Nethercott D
Clin Colorectal Cancer; 2013 Mar; 12(1):70-2. PubMed ID: 22917935
[No Abstract] [Full Text] [Related]
54. Response of Malignant Thymoma to Sorafenib.
Bolzacchini E; Chini C; Pinotti G
J Thorac Oncol; 2016 Oct; 11(10):e125-6. PubMed ID: 27663400
[No Abstract] [Full Text] [Related]
55. [Advances in the clinical study and chemotherapy of thymoma].
Liu X; Xing Z
Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):563-5. PubMed ID: 10436962
[No Abstract] [Full Text] [Related]
56. Fatal Simultaneous Multi-organ Failure Following Pembrolizumab Treatment for Refractory Thymoma.
Hyun JW; Kim GS; Kim SH; Cho JY; Kim HJ; Lee GK; Kim HJ; Kwon SU
Clin Lung Cancer; 2020 Mar; 21(2):e74-e77. PubMed ID: 31718909
[No Abstract] [Full Text] [Related]
57. Regression of invasive thymoma following corticosteroid therapy.
Termeer A; Visser FJ; Mravunac M
Neth J Med; 2001 Apr; 58(4):181-4. PubMed ID: 11325496
[TBL] [Abstract][Full Text] [Related]
58. [EBV reactivation in a patient undergoing chemotherapy for invasive thymoma].
Giordano S; Pampinella D; Alù M; Agostara B; Romano A
Infez Med; 2007 Sep; 15(3):195-8. PubMed ID: 17940405
[TBL] [Abstract][Full Text] [Related]
59. A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins.
Kanzaki M; Wada J; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Nasu J; Yamamoto K; Makino H
Intern Med; 2012; 51(6):619-23. PubMed ID: 22449671
[TBL] [Abstract][Full Text] [Related]
60. Immune Checkpoint Inhibitor-induced Fatal Myositis in a Patient With Squamous Cell Carcinoma and a History of Thymoma.
Luecke E; Ganzert C; Vielhaber S; Haybaeck J; Jechorek D; Mawrin C; Schreiber J
Clin Lung Cancer; 2020 Jul; 21(4):e246-e249. PubMed ID: 32081528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
